scalability

Oncology

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Market Access

Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.

Digital

The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.

Digital

As AI becomes more embedded within national health system priorities, the need for clear and responsible guardrails has become increasingly critical.

R&D

As discovery becomes faster and more accessible, the differentiator shifts downstream.

Sales & Marketing

Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.